Healthcare -
Biotechnology - NASDAQ - US
$ 3.12
-8.5 %
$ 529 M
Market Cap
-1.32
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Relay Therapeutics, Inc.
| Revenue | 25.5 M |
| Cost Of Revenue | 5.27 M |
| Gross Profit | 20.3 M |
| Operating Expenses | 399 M |
| Operating Income | -373 M |
| Other Expenses | -31 M |
| Net Income | -342 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 25.5 | 1.4 | 3.0 | 82.7 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 5.3 | 4.1 | 3.9 | 3.5 | 2.8 | 2.2 |
| Gross Profit | 20.3 | (2.7) | (0.9) | 79.1 | (2.8) | (2.2) |
| OPERATING INCOME | ||||||
| Operating Expenses | 398.5 | 312.3 | 230.0 | 138.4 | 84.0 | 49.9 |
| Selling, General and Administrative Expenses | 75.0 | 66.0 | 57.4 | 38.6 | 13.7 | 8.9 |
| Research and Development Expenses | 330.0 | 246.4 | 172.7 | 99.9 | 70.3 | 41.0 |
| Operating Income | (373.0) | (299.3) | (364.7) | (55.8) | (84.0) | (49.9) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 31.0 | 8.8 | 0.8 | 3.4 | 8.7 | 1.1 |
| Pre-Tax Income | (342.0) | (290.5) | (363.9) | (52.4) | (75.3) | (48.8) |
| NET INCOME | ||||||
| Tax Provision | 0 | (36.2) | 132.9 | (3.4) | (8.8) | 1.1 |
| Net Income | (342.0) | (254.3) | (496.8) | (49.0) | (66.5) | (48.8) |
| EPS | 2.79 | 2.27 | 5.22 | 1.15 | 15.5 | 19.6 |